LEON Team to Attend CPHI Japan 2025 – Meet Us in Tokyo!
We’re excited to announce that the LEON team will be attending CPHI Japan 2025 in Tokyo from April 9–11.
Visit us at stand 5R-25 and explore our cutting-edge solutions:
- Live Demonstration of NANOlab® – See our technology in action
- Explore Our Innovative Solutions – Learn how we can support your needs
- Discuss Future Collaboration Opportunities – Let’s build the future together
Schedule a meeting – Contact us in advance to set up a meeting and discuss how we can collaborate.
About LEON
leon-nanodrugs GmbH is a Munich-based pharmatech company specializing in the development of devices for the encapsulation of genetic material and other pharmaceutical active substances into nanocarriers, such as lipid nanoparticles (LNPs). LEON builds its innovative solutions based on its proprietary FR-JET® Technology. Its portfolio of devices, NANOscreen® for simplified formulation screening, NANOlab® for process development, and NANOme® and NANOus® for GMP aseptic manufacturing, enable faster route to clinical batches and are suitable for both individualised scales and commercial production.
LEON’s platform is aimed at enabling pharma companies, small biotech, research institutes, as well as CDMOs, to take full advantage of the significant progress being made in advanced therapies.
For general information and enquiries please email info@leon-nanodrugs.com